Marcela M. Cordero Garcia

Array ( [id] => 17119694 [patent_doc_number] => 11130816 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-09-28 [patent_title] => Site-specific antibody-drug conjugation through glycoengineering [patent_app_type] => utility [patent_app_number] => 16/238932 [patent_app_country] => US [patent_app_date] => 2019-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 36 [patent_no_of_words] => 27003 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16238932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14596839 [patent_doc_number] => 10351602 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2019-07-16 [patent_title] => Antimicrobial analogues of gramicidin S [patent_app_type] => utility [patent_app_number] => 16/234880 [patent_app_country] => US [patent_app_date] => 2018-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 12567 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16234880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18764030 [patent_doc_number] => 11814416 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-11-14 [patent_title] => Polypeptide capable of passing through blood-brain barrier [patent_app_type] => utility [patent_app_number] => 17/277552 [patent_app_country] => US [patent_app_date] => 2018-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 6250 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17277552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15243433 [patent_doc_number] => 10507226 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2019-12-17 [patent_title] => N-amino peptide beta-sheet mimics for the treatment of Alzheimer's disease [patent_app_type] => utility [patent_app_number] => 16/231086 [patent_app_country] => US [patent_app_date] => 2018-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 11117 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16231086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14213885 [patent_doc_number] => 20190119327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-04-25 [patent_title] => SELECTIVE DELIVERY MOLECULES AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 16/228488 [patent_app_country] => US [patent_app_date] => 2018-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49597 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -220 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16228488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16413271 [patent_doc_number] => 10821133 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-03 [patent_title] => Methods for preserving and administering pre-beta high density lipoprotein extracted from human plasma [patent_app_type] => utility [patent_app_number] => 16/225210 [patent_app_country] => US [patent_app_date] => 2018-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 15230 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16225210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18102438 [patent_doc_number] => 11542313 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-01-03 [patent_title] => Incretin analogs and uses thereof [patent_app_type] => utility [patent_app_number] => 16/768960 [patent_app_country] => US [patent_app_date] => 2018-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10223 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16768960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18779112 [patent_doc_number] => 11820805 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-11-21 [patent_title] => Conjugate based systems for controlled insulin delivery [patent_app_type] => utility [patent_app_number] => 16/771818 [patent_app_country] => US [patent_app_date] => 2018-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 32482 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16771818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14102279 [patent_doc_number] => 20190092815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-28 [patent_title] => PEPTIDE COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 16/216116 [patent_app_country] => US [patent_app_date] => 2018-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11791 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16216116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16756583 [patent_doc_number] => 10975120 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-13 [patent_title] => Site-specific chemoenzymatic protein modifications [patent_app_type] => utility [patent_app_number] => 16/204557 [patent_app_country] => US [patent_app_date] => 2018-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 26603 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16204557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14069377 [patent_doc_number] => 20190083576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-21 [patent_title] => CARRIER-FREE BIOLOGICALLY-ACTIVE PROTEIN NANOSTRUCTURES [patent_app_type] => utility [patent_app_number] => 16/195128 [patent_app_country] => US [patent_app_date] => 2018-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13444 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16195128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15782485 [patent_doc_number] => 10624945 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-04-21 [patent_title] => Use of an all-D-pentapeptide chemokine antagonist to reduce opioid dose in a person with pain [patent_app_type] => utility [patent_app_number] => 16/177344 [patent_app_country] => US [patent_app_date] => 2018-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 12 [patent_no_of_words] => 2170 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16177344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16282720 [patent_doc_number] => 20200276322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-03 [patent_title] => PEPTIDE COMPOSITIONS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/758791 [patent_app_country] => US [patent_app_date] => 2018-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30515 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -97 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16758791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17620159 [patent_doc_number] => 11339197 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-24 [patent_title] => Modified EGF protein, production method therefor, and use thereof [patent_app_type] => utility [patent_app_number] => 16/757823 [patent_app_country] => US [patent_app_date] => 2018-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 7601 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16757823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16138937 [patent_doc_number] => 10702522 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-07-07 [patent_title] => Methods and compositions for sleep disorders and other disorders [patent_app_type] => utility [patent_app_number] => 16/165832 [patent_app_country] => US [patent_app_date] => 2018-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11310 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16165832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16345147 [patent_doc_number] => 20200309797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-01 [patent_title] => SELECTION BIOMARKERS FOR PATIENT STRATIFICATION IN BODILY FLUIDS AND APPLYING PRECISION MEDICINE THROUGH NOVEL DIAGNOSTIC BIOMARKERS [patent_app_type] => utility [patent_app_number] => 16/753418 [patent_app_country] => US [patent_app_date] => 2018-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9478 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16753418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18273718 [patent_doc_number] => 11612639 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-03-28 [patent_title] => Methods and compositions for rejuvenating skeletal muscle stem cells [patent_app_type] => utility [patent_app_number] => 16/154691 [patent_app_country] => US [patent_app_date] => 2018-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 28 [patent_no_of_words] => 26644 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16154691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14156597 [patent_doc_number] => 20190105401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-04-11 [patent_title] => PEPTIDE-MEDIATED DRUG DELIVERY ACROSS EPITHELIAL BARRIER [patent_app_type] => utility [patent_app_number] => 16/151484 [patent_app_country] => US [patent_app_date] => 2018-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18345 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16151484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17074900 [patent_doc_number] => 11111285 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-09-07 [patent_title] => Glucagon-GLP-1-GIP triple agonist compounds [patent_app_type] => utility [patent_app_number] => 16/151603 [patent_app_country] => US [patent_app_date] => 2018-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11671 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16151603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16734432 [patent_doc_number] => 10960053 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-30 [patent_title] => PEGylated recombinant human growth hormone compounds [patent_app_type] => utility [patent_app_number] => 16/146253 [patent_app_country] => US [patent_app_date] => 2018-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 23592 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 346 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16146253 [rel_patent_id] =>[rel_patent_doc_number] =>)